Ken Acajou, Deputy CEO CFAO Healthcare, Biju Mohandas, Partner
& Global Head, Healthcare at LeapFrog Investments, Jean-Marc LECCIA, CEO of
CFAO Healthcare, Justin Melvin, CEO, Goodlife Kenya.
CFAO
Healthcare has announced its full acquisition of Goodlife
Pharmacy, giving it full control of the pharmaceutical outlets across
Kenya and Uganda.
The acquisition
process was announced
during a press conference in Nairobi.
Speaking
during the handover ceremony, CFAO Healthcare CEO Jean -Marc Leccia said that
the move confirms the company's expansion into East Africa’s
retail health market.
“By
acquiring 100 per cent of Goodlife Pharmacy, we are accelerating our transformation
into a global healthcare player. Together, we will enhance accessibility,
service quality and innovation in the pharmaceutical sector,” he said.
He reiterated they have no intention of altering the ‘Goodlife’ brand and are determined to maintain the name.
He confirmed that the deal had received all necessary regulatory approvals and is effective immediately.
According to Justin Melvin, CEO, Goodlife Kenya, the company was founded in 2014 and serves over 2 million patients each year. He said that
the company had established itself as a leading brand through a multichannel
offering that combines modern retail pharmacies, rapid diagnostics,
telemedicine, e-commerce and home delivery.
Justin Melvin expressed his satisfaction with the full
acquisition of the outfit, stating that they had fulfilled their mission in
delivering and promoting good health and well-being.
The CEO of LeapFrog Investments, Partner and Head of Global Healthcare Investments Dr Biju Mohandas, acknowledged his full faith in the acquisition.
He said, "CFAO Healthcare is the right long-term partner to amplify Goodlife’s impact and drive the next phase of its expansion."
Kenya’s retail pharmaceutical sector—which includes both pharmacies (prescription drugs) and OTC (over‑the‑counter) products—is a dynamic and growing market, currently forecast to generate roughly US$1.21 billion in pharmacy retail revenue in 2025, with an expected CAGR of about 4.7% through 2029, according to Statista.
